Report

The United Kingdom heart valve devices market was valued at USD 3.69 Billion in 2024, driven by the increasing incidence of valvular heart diseases such as aortic stenosis and mitral regurgitation in the region. The market is anticipated to grow at a CAGR of 9.50% during the forecast period of 2025-2034, with the values likely to reach USD 9.14 Billion by 2034.

United Kingdom Heart Valve Devices Market Overview

The market is experiencing significant growth, driven by advancements in medical technology, an aging population, and increasing awareness of cardiovascular health. The UK's aging population is another key market driver, as valvular heart diseases such as aortic stenosis and mitral regurgitation are more common among older individuals. The demand for biological (tissue) valves, which require less long-term care compared to mechanical valves, is particularly high, aligning with healthcare preferences for less invasive, patient-friendly treatments. Moreover, the growing awareness of cardiovascular health, coupled with the NHS's initiatives to improve cardiovascular care, is expected to support the market expansion in the forecast period.

United Kingdom Heart Valve Devices Market Growth Drivers

Rising Prevalence of Cardiovascular Diseases to Support Market Growth

Heart valve disease is prevalent in the United Kingdom, affecting approximately 11.3% of people over the age of 65. The rising burden of heart valve disease, particularly among the aging population, is a primary driver of growth in the heart valve devices market. As individuals age, the incidence of valvular heart diseases like aortic stenosis and mitral regurgitation increases, further contributing to the demand for effective valve replacement and repair solutions.

United Kingdom Heart Valve Devices Market Trends

The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:

Rising Strategic Investments to Boost Market Growth

In March 2025, Boston Scientific invested USD 175 million in 4C Medical Technologies, a company developing minimally invasive devices for structural heart disease. This funding will support the ongoing pivotal ATLAS trial of 4C Medical's AltaValve transcatheter mitral valve replacement (TMVR) device in Europe and the United States. The AltaValve system is the world's only fully retrievable and low-profile TMVR system, designed to address mitral regurgitation (MR) in patients unsuitable for surgery or transcatheter edge-to-edge repair. Such strategic investments are expected to boost market growth in the forecast period.

Shift Toward Minimally Invasive Procedures to Elevate the United Kingdom Heart Valve Devices Market Value

One of the major market trends is the rising shift from traditional open-heart surgeries to less invasive interventions, such as transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve replacement (TMVR). These procedures are associated with reduced recovery times, fewer complications, and are better suited for elderly or high-risk patients.

United Kingdom Heart Valve Devices Market Segmentation

The market report offers a detailed analysis of the market based on the following segments:

Market Breakup by Valve Type

- Biological (Tissue) Valve
- Mechanical Valve

Market Breakup by Product Type

- Replacement Devices
??- Mechanical Valve
??- Bioprosthetic Valve
??- Transcatheter Aortic Valve Replacement (TAVR)

- Repair Devices

??- Surgical Valve
??- Transcatheter Mitral Valve Replacement (TMVR)
??- Balloon Valvuloplasty Devices

Market Breakup by Procedure

- Open Surgery
- Minimally Invasive Surgery (MIS)

Market Breakup by End User

- Hospitals
- Ambulatory Surgical Centers (ASCs)
- Others

United Kingdom Heart Valve Devices Market Share

Segmentation Based on Valve Type to Hold a High Market Value

Based on the valve type, the market is segmented into biological (tissue) valve and mechanical valve. ?In the United Kingdom, the biological (tissue) valve segment holds a substantial market share, primarily due to its growing preference among elderly patients and those looking to avoid long-term anticoagulation therapy required with mechanical valves. These valves are increasingly used in both surgical and transcatheter procedures, including TAVR, and are supported by evolving clinical guidelines that favor tissue valves for patients over a certain age or with lifestyle considerations.

United Kingdom Heart Valve Devices Market Analysis by Region

The market shows varied growth patterns across different regions, influenced by healthcare accessibility, demographic profiles, and the distribution of specialized cardiac centers. In Northern England, treatment rates are notably higher, indicating more active adoption of valve interventions in certain areas. On the other hand, Southern regions tend to show relatively lower treatment rates, revealing opportunities for further market development and improved access to advanced cardiac care.

Leading Players in the United Kingdom Heart Valve Devices Market

The key features of the market report comprise patent analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:

Medtronic plc

Medtronic plc, headquartered in Ireland, offers a comprehensive range of transcatheter and surgical heart valves. The company's Evolut platform is widely used across NHS trusts and private hospitals, offering alternatives for patients unfit for open-heart surgery. Medtronic supports UK-based training programs, clinical trials, and registry data collection, helping to shape clinical guidelines and improve access to advanced care.

Edwards Lifesciences Corporation

Edwards Lifesciences is a U.S.-based company specializing in structural heart disease, critical care, and surgical monitoring technologies. In the UK, the company has made a significant impact with its SAPIEN transcatheter valve series, which is widely used across NHS and private hospitals. Edwards actively collaborates on clinical research and national registry programs, helping to validate the safety and long-term effectiveness of its devices.

Abbott

Abbott is recognized for its role in expanding transcatheter mitral valve repair (TMVr) in the UK, particularly through its MitraClip system. MitraClip has become a leading therapeutic option for patients with mitral regurgitation who are not suitable candidates for open-heart surgery. Abbott has also reinforced its presence in the transcatheter aortic valve replacement (TAVR) space with the introduction of the Portico and Navitor systems.

Corcym Group

Corcym is one of the key market players in the surgical heart valve segment. Its sutureless valve technology (Perceval) enables faster surgical procedures and recovery, making it a valuable solution in high-volume centers. The company contributes to ongoing UK cardiac surgery education and partners with surgeons to optimize outcomes for complex valve repair and replacement cases.

Other key players in the market include Boston Scientific Corporation, B. Braun SE, Getinge AB, JenaValve Technology, Inc., and Meril Life Sciences Pvt. Ltd.

Key Questions Answered in the United Kingdom Heart Valve Devices Market Report

- What was the United Kingdom heart valve devices market value in 2024?
- What is the United Kingdom heart valve devices market forecast outlook for 2025-2034?
- What is the market segmentation based on valve type?
- What is the market segmentation based on product type?
- What is the market breakup based on the procedure?
- What is the market breakup by end user?
- What major factors aid the United Kingdom heart valve devices market demand?
- How has the market performed so far and how is it anticipated to perform in the coming years?
- What are the major drivers, opportunities, and restraints in the market?
- What are the major trends influencing the market?
- Who are the key players involved in the United Kingdom heart valve devices market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?